title: Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause.
abstract: To define the relative frequency of phenotypes of transplant glomerulopathy, we retrospectively reviewed the findings in 1036 biopsies for clinical indications from 1320 renal transplant patients followed in our clinics between 1997 and 2005. Transplant glomerulopathy, defined by double contours of glomerular basement membranes (D), was diagnosed in 53 biopsies (5.1%) from 41 patients (3.1%) at a median of 5.5 years post-transplant (range 3.8-381 months). In cases with D, we studied the frequency of circulating anti-HLA alloantibody (A), peritubular capillary basement membrane multilayering (B) and peritubular capillary C4d deposition (C). B was present in 48 (91%) of D biopsies. C4d staining by indirect immunofluorescence was detected in 18 of 50 D biopsies studied (36%). By Flow PRA Screening or ELISA, A was detected in 33 (70%) in 47 D cases with available sera, of which 28/33 or 85% were donor-specific. Class II (13/33) or class I and II (17/33) were more common than class I (3/33) antibodies. Thus 73% of transplant glomerulopathy has evidence of alloantibody-mediated injury (A and/or C), with ABCD and ABD being the common phenotypes in biopsies for cause. The remaining 27%, mostly BD, may be a different disease or a stage in which A and C are undetectable.
authors.affiliation: Laboratory Medicine and Pathology, and Medicine, Division of Nephrology and Transplantation Immunology, University of Alberta, Edmonton, AB, Canada.
authors.forename: B
authors.initials: B
authors.lastname: Sis
authors.forename: P M
authors.initials: PM
authors.lastname: Campbell
authors.forename: T
authors.initials: T
authors.lastname: Mueller
authors.forename: C
authors.initials: C
authors.lastname: Hunter
authors.forename: S M
authors.initials: SM
authors.lastname: Cockfield
authors.forename: J
authors.initials: J
authors.lastname: Cruz
authors.forename: C
authors.initials: C
authors.lastname: Meng
authors.forename: D
authors.initials: D
authors.lastname: Wishart
authors.forename: K
authors.initials: K
authors.lastname: Solez
authors.forename: P F
authors.initials: PF
authors.lastname: Halloran
mesh_terms: D001706:Biopsy; D006084:Graft Rejection / Q000276:immunology / Q000473:pathology*; D006680:HLA Antigens / Q000276:immunology; D006801:Humans; D007518:Isoantibodies / Q000032:analysis; D007519:Isoantigens / Q000276:immunology; D007678:Kidney Glomerulus / Q000276:immunology / Q000473:pathology*; D016030:Kidney Transplantation / Q000276:immunology / Q000473:pathology*; D011183:Postoperative Complications / Q000453:epidemiology / Q000473:pathology*; D012189:Retrospective Studies; D014184:Transplantation, Homologous / Q000276:immunology / Q000473:pathology
chemical_list: D006680:HLA Antigens; D007518:Isoantibodies; D007519:Isoantigens